105 related articles for article (PubMed ID: 34408879)
41. Post COVID-19 neuropsychiatric complications and therapeutic role for TNF-α inhibitors: a case series study.
Shafiee G; Arastou T; Heshmat R; Jamshidi AR; Larijani B; Arzaghi SM
J Diabetes Metab Disord; 2022 Dec; 21(2):2013-2016. PubMed ID: 36267491
[TBL] [Abstract][Full Text] [Related]
42. Just When We Thought That COVID Was Over: A Systematic Review.
Tariq M; Acharekar MV; Guerrero Saldivia SE; Unnikrishnan S; Chavarria YY; Akindele AO; Jalkh AP; Eastmond AK; Shetty C; Rizvi SMHA; Sharaf J; Williams KD; Balani P
Cureus; 2022 Jul; 14(7):e27441. PubMed ID: 36060385
[TBL] [Abstract][Full Text] [Related]
43. Neurological Symptoms Due To Severe Acute Respiratory Syndrome Coronavirus 2 Infection Require Thorough Evaluation and Assignment to a Diagnosis.
Finsterer J
Pediatr Neurol; 2024 Jan; 150():43. PubMed ID: 37952259
[No Abstract] [Full Text] [Related]
44. Persistent clinical manifestations at 3 and 6 months after severe acute respiratory syndrome coronavirus 2 infection.
Rosales-Castillo A; Bustos-Merlo A; Mediavilla García JD
Med Clin (Engl Ed); 2022 Apr; 158(8):388-389. PubMed ID: 35463206
[No Abstract] [Full Text] [Related]
45. Post-COVID 19 neurological syndrome: The need to define a cut-off score between the acute and post-COVID 19 phases.
Rodríguez-Hernández YA; Villamizar-Gómez FJ; Mantilla-Pardo JC; Robledo-Arias JS; Rahman S; Lozada-Martinez ID; Bin Razzak KS
Ann Med Surg (Lond); 2021 Nov; 71():102983. PubMed ID: 34745603
[No Abstract] [Full Text] [Related]
46. Revisiting the jumping to conclusions bias in functional movement disorders.
Sainz-Amo R; Morillo-González J; Gómez-Corral J; Moreno C; Alonso Cánovas A; Castrillo JCM; Edwards MJ; Hernández-Huerta D; Pareés I
J Neurol Neurosurg Psychiatry; 2024 Mar; ():. PubMed ID: 38453476
[No Abstract] [Full Text] [Related]
47. [Functional neurological disorders in post COVID-19 patients. Case series].
Albu S; Guven Z; Vallés M; Kumru H
Neurologia; 2023; 38(1):58-59. PubMed ID: 35250140
[No Abstract] [Full Text] [Related]
48. Is Long Covid a Functional Disorder?
Pick A
Adv Rehabil Sci Pract; 2023; 12():11795727221141193. PubMed ID: 36891136
[No Abstract] [Full Text] [Related]
49. The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease.
Adeloye D; Elneima O; Daines L; Poinasamy K; Quint JK; Walker S; Brightling CE; Siddiqui S; Hurst JR; Chalmers JD; Pfeffer PE; Novotny P; Drake TM; Heaney LG; Rudan I; Sheikh A; De Soyza A;
Lancet Respir Med; 2021 Dec; 9(12):1467-1478. PubMed ID: 34416191
[TBL] [Abstract][Full Text] [Related]
50. Charting a course for the management of long COVID.
Beasley R; Kearns N; Hills T
Lancet Respir Med; 2021 Dec; 9(12):1358-1360. PubMed ID: 34416190
[No Abstract] [Full Text] [Related]
51. Fatigue in post-acute sequelae of SARS-CoV2 (PASC) treated with oxygen-ozone autohemotherapy - preliminary results on 100 patients.
Tirelli U; Franzini M; Valdenassi L; Pisconti S; Taibi R; Torrisi C; Pandolfi S; Chirumbolo S
Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5871-5875. PubMed ID: 34604980
[TBL] [Abstract][Full Text] [Related]
52. Post-COVID-19 opsoclonus-myoclonus syndrome and encephalopathy associated with leucine-rich glioma-inactivated 1 (LGI-1) antibodies.
Smyth D; Kyaw KM; Legister A; MacFarlane G; Sankar UU; Patel M; Clough C; Kulendran A; Mulroy E
J Neurol Sci; 2021 Nov; 430():119982. PubMed ID: 34543933
[No Abstract] [Full Text] [Related]
53. Follow-Ups on Persistent Symptoms and Pulmonary Function Among Post-Acute COVID-19 Patients: A Systematic Review and Meta-Analysis.
Long Q; Li J; Hu X; Bai Y; Zheng Y; Gao Z
Front Med (Lausanne); 2021; 8():702635. PubMed ID: 34540862
[No Abstract] [Full Text] [Related]
54. Long-term neurological manifestations of COVID-19: prevalence and predictive factors.
Pilotto A; Cristillo V; Cotti Piccinelli S; Zoppi N; Bonzi G; Sattin D; Schiavolin S; Raggi A; Canale A; Gipponi S; Libri I; Frigerio M; Bezzi M; Leonardi M; Padovani A
Neurol Sci; 2021 Dec; 42(12):4903-4907. PubMed ID: 34523082
[TBL] [Abstract][Full Text] [Related]
55. De Novo Movement Disorders Associated with COVID-19- A Systematic Review of Individual Patients.
Pillai KS; Misra S; Siripurapu G; Aliyar A; Bhat P; Rajan R; Srivastava A; Goyal V; Venkitachalam A; Radhakrishnan DM
Ann Indian Acad Neurol; 2023; 26(5):702-707. PubMed ID: 38022478
[TBL] [Abstract][Full Text] [Related]
56. Movement Disorders and SARS-CoV-2.
Fung WKW; Fasano A; Fearon C
Mov Disord Clin Pract; 2023 Aug; 10(Suppl 2):S9-S17. PubMed ID: 37637980
[No Abstract] [Full Text] [Related]
57. Late neurological consequences of SARS-CoV-2 infection: New challenges for the neurologist.
Korchut A; Rejdak K
Front Neurosci; 2023; 17():1004957. PubMed ID: 36845421
[TBL] [Abstract][Full Text] [Related]
58. The onset of functional movement disorders after COVID-19: A case series.
Shishorin R; Gamirova A; Tolmacheva V; Petelin D; Volel B
Indian J Psychiatry; 2022; 64(5):529-532. PubMed ID: 36458078
[TBL] [Abstract][Full Text] [Related]
59. Neurological Manifestations of SARS-CoV2 Infection: A Narrative Review.
Pavel B; Moroti R; Spataru A; Popescu MR; Panaitescu AM; Zagrean AM
Brain Sci; 2022 Nov; 12(11):. PubMed ID: 36421855
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
